FRANCISCO JAVIER
LÓPEZ LONGO
Investigador fins a 2019
![Foto de FRANCISCO JAVIER](/img/nophoto.png)
![Foto de Hospital Universitario Príncipe de Asturias](/img/noimage_org.png)
Hospital Universitario Príncipe de Asturias
Alcalá de Henares, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario Príncipe de Asturias (15)
2022
-
Clinical Characteristics of Juvenile Idiopathic Inflammatory Myopathy and Comparison with Adult Patients Analysis from a Multicentric Cohort in Spain
Journal of Clinical Rheumatology, Vol. 28, Núm. 1, pp. E195-E202
2021
-
Protocolised odontological assessment of patients with primary Sjögren's syndrome
Reumatologia Clinica, Vol. 17, Núm. 1, pp. 25-31
2020
-
Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662
-
Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry
Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 110-115
-
Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome
Rheumatology International, Vol. 40, Núm. 8, pp. 1259-1265
2019
-
Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease
Clinical Rheumatology, Vol. 38, Núm. 3, pp. 803-815
-
Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry
International Journal of Rheumatic Diseases, Vol. 22, Núm. 8, pp. 1393-1401
2017
-
Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain
Rheumatology International, Vol. 37, Núm. 11, pp. 1853-1861
-
Multicenter registry on inflammatory myositis from the Rheumatology Society in Madrid, Spain: Descriptive Analysis
Reumatologia Clinica, Vol. 13, Núm. 6, pp. 331-337
2016
-
Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)
Medicine (United States), Vol. 95, Núm. 9
-
Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis
PLoS ONE, Vol. 11, Núm. 9
-
Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry
Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250
2015
-
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain
Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 633-640
2014
-
The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: Results from a nationwide cohort in Spain (LESIMAB)
Lupus, Vol. 23, Núm. 10, pp. 1014-1022
2012
-
Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: The LESIMAB study
Lupus, Vol. 21, Núm. 10, pp. 1063-1076